Lymph node metastasis and pattern of recurrence in clinically early stage endometrial cancer with positive lymphovascular space invasion
- PMID: 25686395
- PMCID: PMC4510337
- DOI: 10.3802/jgo.2015.26.3.208
Lymph node metastasis and pattern of recurrence in clinically early stage endometrial cancer with positive lymphovascular space invasion
Abstract
Objective: To investigate the rate, predictors of lymph node metastasis (LNM) and pattern of recurrence in clinically early stage endometrial cancer (EC) with positive lymphovascular space invasion (LVSI).
Methods: Women with clinically early stage EC and positive LVSI 2005 to 2012 were identified. Kaplan-Meier curves and logistic regression models were used.
Results: One hundred forty-eight women were identified. Of them, 25.7% had LNM (21.7% pelvic LNM, 18.5% para-aortic LNM). Among patients with LNM who had both pelvic and para-aortic lymphadenectomy, isolated pelvic, para-aortic and both LNM were noted in 51.4%, 17.1%, and 31.4% respectively. Age and depth of myometrial invasion were significant predictors of LNM in LVSI positive EC. Node positive patients had high recurrence rate (47% vs. 11.8%, p<0.05) especially distant (60.9% vs. 7.9%, p<0.001) and para-aortic (13.2% vs. 1.8%, p=0.017) recurrences compared to node negative EC. LNM was associated with lower progression-free survival (p=0.002) but not overall survival (p=0.73).
Conclusion: EC with positive LVSI is associated with high risk of LNM. LNM is associated with high recurrence rate especially distant and para-aortic recurrences. Adjuvant treatments should target prevention of recurrences in these areas.
Keywords: Endometrial Neoplasms; Lymph Nodes; Lymphovascular Space Invasion; Recurrence; Retrospective Studies; Survival.
Conflict of interest statement
Figures
![Fig. 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4510337/bin/jgo-26-208-g001.gif)
Similar articles
-
Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.Gynecol Oncol. 2005 Mar;96(3):651-7. doi: 10.1016/j.ygyno.2004.11.026. Gynecol Oncol. 2005. PMID: 15721407
-
Lymphovascular space invasion is highly associated with lymph node metastasis and recurrence in endometrial cancer.Aust N Z J Obstet Gynaecol. 2013 Jun;53(3):293-7. doi: 10.1111/ajo.12089. Epub 2013 Apr 22. Aust N Z J Obstet Gynaecol. 2013. PMID: 23600915
-
Lymphovascular space invasion and positive pelvic lymph nodes are independent risk factors for para-aortic nodal metastasis in endometrioid endometrial cancer.Eur J Obstet Gynecol Reprod Biol. 2015 Mar;186:63-7. doi: 10.1016/j.ejogrb.2015.01.006. Epub 2015 Jan 23. Eur J Obstet Gynecol Reprod Biol. 2015. PMID: 25638600
-
[Is there an interest in para-aortic lymphadenectomy in operable endometrial cancer?].Bull Cancer. 2010 Feb;97(2):199-209. doi: 10.1684/bdc.2009.0956. Bull Cancer. 2010. PMID: 19812008 Review. French.
-
Stage IB endometrial cancer. Does lymphadenectomy replace adjuvant radiotherapy?Strahlenther Onkol. 2007 Nov;183(11):600-4. doi: 10.1007/s00066-007-1801-3. Strahlenther Onkol. 2007. PMID: 17960334 Review.
Cited by
-
Demographic Factors Predict Risk of Lymph Node Involvement in Patients with Endometrial Adenocarcinoma.Biology (Basel). 2023 Jul 10;12(7):982. doi: 10.3390/biology12070982. Biology (Basel). 2023. PMID: 37508411 Free PMC article.
-
The impact of lymphovascular space invasion on survival in early stage low-grade endometrioid endometrial cancer.Eur J Med Res. 2023 Mar 13;28(1):118. doi: 10.1186/s40001-023-01084-9. Eur J Med Res. 2023. PMID: 36915143 Free PMC article.
-
Alternative ANKHD1 transcript promotes proliferation and inhibits migration in uterine corpus endometrial carcinoma.NPJ Genom Med. 2022 Sep 29;7(1):56. doi: 10.1038/s41525-022-00321-0. NPJ Genom Med. 2022. PMID: 36171217 Free PMC article.
-
A detailed analysis of lymph node recurrence in endometrial carcinoma.Transl Cancer Res. 2022 Jul;11(7):2217-2224. doi: 10.21037/tcr-21-2588. Transl Cancer Res. 2022. PMID: 35966308 Free PMC article.
-
Systemic Immune-Inflammatory Index as a Predictor of Lymph Node Metastasis in Endometrial Cancer.J Inflamm Res. 2021 Dec 21;14:7131-7142. doi: 10.2147/JIR.S345790. eCollection 2021. J Inflamm Res. 2021. PMID: 34992410 Free PMC article.
References
-
- Hahn HS, Lee IH, Kim TJ, Lee KH, Shim JU, Kim JW, et al. Lymphovascular space invasion is highly associated with lymph node metastasis and recurrence in endometrial cancer. Aust N Z J Obstet Gynaecol. 2013;53:293–297. - PubMed
-
- Mariani A, Webb MJ, Keeney GL, Aletti G, Podratz KC. Predictors of lymphatic failure in endometrial cancer. Gynecol Oncol. 2002;84:437–442. - PubMed
-
- Briet JM, Hollema H, Reesink N, Aalders JG, Mourits MJ, ten Hoor KA, et al. Lymphvascular space involvement: an independent prognostic factor in endometrial cancer. Gynecol Oncol. 2005;96:799–804. - PubMed
-
- Cohn DE, Horowitz NS, Mutch DG, Kim SM, Manolitsas T, Fowler JM. Should the presence of lymphvascular space involvement be used to assign patients to adjuvant therapy following hysterectomy for unstaged endometrial cancer? Gynecol Oncol. 2002;87:243–246. - PubMed
-
- Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer. 1987;60(8 Suppl):2035–2041. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical